KEYTRUDA® (pembrolizumab) Pooled Safety
For information regarding KEYTRUDA® (pembrolizumab) pooled safety, please click on the relevant button below for information tailored to your needs.
GB-PDO-01563 | Date of Preparation: April 2021
For UK Healthcare Professionals
This section of MSD Connect is an online portal containing promotional information about MSD pharmaceutical products, therapy area materials and professional resources and is intended for UK Healthcare Professionals.
To contact us please telephone 0208 154 8000 or email medicalinformationuk@msd.com | Privacy Policy | Terms of Use
GB-NON-07197 | Date of Preparation: August 2023
Merck Sharp & Dohme (UK) Limited Registered Office: 120 Moorgate, London, EC2M 6UR, United Kingdom.
Registered in England No. 233687 Copyright © 2023 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Merck Sharp & Dohme (UK) Limited (Tel: 0208 154 8000)